Safety study of ABBV-295 injections in Japanese adults with overweight
This is an early-stage safety study testing a new injectable medication (ABBV-295) in healthy Japanese adults who are overweight or have obesity. The study measures how well the body tolerates the drug and how it moves through the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be of full Japanese descent (born in Japan, or born outside Japan to Japanese-born parents and grandparents)
- Your BMI must be between 23.0 and 35.0 kg/m² (a measure of weight relative to height)
- Your weight must not have changed by 5% or more in the 3 months before screening
- You cannot have diabetes or prediabetes (specific blood sugar levels will be tested)
- You cannot have taken obesity medications or been in another obesity trial in the past 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a new drug called ABBV-859 in healthy volunteers to see how safe it is and how the body processes it. It helps doctors decide the right dose for future studies.
This early-stage trial tests how the body handles a new experimental drug called ABBV-1451, given as either an infusion (IV drip) or injection. Researchers want to make sure it's safe and well-tolerated in healthy volunteers before testing it in people with medical conditions.
This trial tests the safety of a new oral drug, ABBV-1042, in healthy adults. It helps researchers understand how the drug moves through the body and what side effects may occur.
This study tests an injected medication called ABBV-295 for adults with obesity. The goal is to see how safe it is and how the body processes it. You may join if you have a BMI between 30 and 45 and are generally healthy, and you haven't been on other weight loss treatments recently.
This trial tests a new medicine called AZD1043 in healthy adults who are overweight or have obesity. It aims to see if the medicine is safe and how the body handles it.
This trial tests different doses of UBT251, a new medicine, to see how well it helps people lose weight. It may be an option if you have overweight or obesity and meet certain age and BMI requirements.
Hear when a new Healthy Volunteer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.